Disposition of 634 shares by Ginger Gregory of Biogen at 240.98 subject to Rule 16b-3
| BIIB Stock | MXN 3,250 228.71 6.57% |
Slightly above 62% of Biogen's investor base is looking to short. The analysis of current outlook of investing in Biogen Inc suggests that many traders are alarmed regarding Biogen's prospects. Biogen's investing sentiment can be driven by a variety of factors including economic data, Biogen's earnings reports, geopolitical events, and overall market trends.
Biogen |
Filed transaction by Biogen Inc Officer Evp, Human Resources. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Biogen Fundamental Analysis
We analyze Biogen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biogen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
Biogen is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Biogen Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biogen stock to make a market-neutral strategy. Peer analysis of Biogen could also be used in its relative valuation, which is a method of valuing Biogen by comparing valuation metrics with similar companies.
Peers
Biogen Related Equities
| COF | Capital One | 4.24 | ||||
| UNH | UnitedHealth Group | 0.82 | ||||
| SPORTS | Grupo Sports | 0.16 | ||||
| GNW | Genworth Financial | 0.00 | ||||
| BNS | Bank of Nova Scotia | 0.03 | ||||
| COST | Costco Wholesale | 1.72 | ||||
| VZ | Verizon Communications | 2.94 |
Additional Tools for Biogen Stock Analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.